Early use of faecal microbiota transplantation for C. difficile infection

Drug Ther Bull. 2023 Mar;61(3):36. doi: 10.1136/dtb.2023.000003. Epub 2023 Jan 30.

Abstract

Overview of: Baunwall SMD, Andreasen SE, Hansen MM, et al Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 2022;7:1083-91.

Keywords: Drug-Related Side Effects and Adverse Reactions; Health Care Quality, Access, and Evaluation.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Clostridioides difficile*
  • Clostridium Infections*
  • Double-Blind Method
  • Fecal Microbiota Transplantation
  • Feces
  • Humans